05:35 PM EDT, 05/05/2025 (MT Newswires) -- Harlan S Robins, Chief Scientific Officer, on May 01, 2025, sold 68,412 shares in Adaptive Biotechnologies ( ADPT ) for $502,828. Following the Form 4 filing with the SEC, Robins has control over a total of 1,279,524 common shares of the company, with 1,279,524 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1478320/000106299325008509/xslF345X05/form4.xml